BioCentury
ARTICLE | Company News

Epitarget deal

May 28, 2012 7:00 AM UTC

An undisclosed pharma company will supply custom short interfering RNA molecules for Epitarget to test on its ultrasound triggered siRNA delivery platform. Epitarget and its academic partner French National Institute of Health and Medical Research (Inserm) are responsible for in vivo testing. Details were not disclosed. ...